Race Oncology CEO/MD Phil Lynch speaks to Matt Birney of the Bulls n' Bears Report…
19
Feb
MST Access has initiated coverage of Race Oncology with a current $4.88 per share valuation.
The full report can be downloaded below.
MST Access has initiated coverage of Race Oncology with a current $4.88 per share valuation.
The full report can be downloaded below.
